The Asia Pacific Nephrology and Urology Devices Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 35,161.8 thousand units, showcasing a growth of 6.4% (2019-2022).
It is expected that the market will experience a surge in the purchase of nephrology and urology devices, propelled by the growing need for minimally invasive procedures made possible by recent technological developments. Stents for the ureter, catheters, guidewires, and renal dilators are among the apparatuses that are manufactured utilizing cutting-edge substances like silicone, polyurethanes/polycarbonates, and nitinol. Carbothane exhibits chemical resistance, including that of iodine, hydrogen peroxide, and alcohol, extending its operational lifespan. Carbothane, utilized in the MAHURKAR Chronic Carbothane catheter developed by Medtronic, provides superior kink resistance, facilitates insertion, and permits high flow rates with minimal pressure in the arteries and veins.
A substantial senior population, which is exceptionally prone to numerous diseases such as kidney and urinary disorders, is anticipated to propel the market. The advancing age of an individual is widely recognized as a substantial risk factor in the onset of numerous medical conditions. The immune system is compromised with advancing age, rendering individuals more susceptible to ailments including urinary retention, diabetes, prostate cancer, and renal complications.
The rising healthcare expenditure in Asia Pacific, driven by economic growth and increased government spending on healthcare, supports investments in medical devices. Several Asian Pacific governments are implementing initiatives to improve healthcare infrastructure and services. Nephrology and urology devices play a crucial role in these preventive measures. Due to the aforementioned factors the market growth will drive in this region.
The China market dominated the Asia Pacific Nephrology and Urology Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $669 million by 2030. The Japan market is registering a CAGR of 6.2% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.7% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Application, the market is segmented into Kidney Diseases, Bladder Disorders, Urolithiasis, Urological Cancer & BPH, and Others. Based on Product, the market is segmented into Urology Guidewires, Stone Basket, Renal Dilators, Mesh & Inserts, Ureteral Catheters, Urinary Stents, PCN Catheters, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Nephrology And Urology Devices Market is Predict to reach $8.5 Billion by 2030, at a CAGR of 6.3%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
